Project profile — Support to COVID-19 Diagnostics

• Asia, regional (20.00%)
• America, regional (20.00%)
• Oceania, regional (20.00%)
• Europe, regional (20.00%)
• Africa, regional (20.00%)

• Basic Health: Infectious disease control (12250) (50.00%)
• Health: COVID-19 control (12264) (50.00%)

• Gender equality (significant objective)

This project builds on Canada’s funding to the Foundation for Innovative New Diagnostics (FIND) during COVID-19. The initial project aims at accelerate the roll-out of safe, affordable, and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. This project supports FIND in using testing technologies developed during COVID-19 to expand the range of diseases detected with a single test. This includes other respiratory diseases, sexually transmitted infections, and Human papillomavirus (HPV)-based screening for cervical cancer. The project aims to increase testing for the most marginalized, including women, children, and vulnerable groups. Project activities include: (1) supporting the development of more straightforward sample collection methods, including self-sampling; and (2) conducting in-country customer preference surveys and barrier-to-access surveys to guide the final development and introduction of tests.

The expected outcomes of this project include: (1) enhanced equitable access to near-patient, accurate, and affordable tests for critical women’s health needs; and (2) enhanced evidence to develop and introduce tests.

N/A

• Proactive disclosure
• Related activities:
• Support to COVID-19 diagnostics
• Support to COVID-19 Diagnostics